Furthermore, cf-mtDNA is involved in the pathogenic progression of nonalcoholic steatohepatitis (NASH), one of the most common liver diseases, activating TLR9 signaling. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatohepatitis.